uniQure director sells shares after exercising options

uniQure N.V. director Jack Kaye reported option exercises and share sales.

(Neutral)

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

uniQure N.V. director Jack Kaye reported option exercises and share sales. On June 30, 2026, he exercised stock options for a total of 21,167 Ordinary Shares at exercise prices of $20.18 and $37.00, then sold the same number of shares in open-market transactions around $46.43–$46.49 per share. These trades were carried out under a pre-arranged Rule 10b5-1 sales plan adopted on June 16, 2025. After these transactions, he directly owned 25,996 Ordinary Shares.

Insider Trade Summary 10b5-1

Exercise and Sale: 21,167 shares ($487K approx. pre-tax spread)

Exercise and Sale 6 txns

Insider Kaye Jack

Role Director

Sold 21,167 shs ($983K)

Approx. gross sale proceeds $983K

Approx. exercise cost $496K

Approx. pre-tax spread $487K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy)	4,107	$0.00	$0.00
Exercise	Stock Option (Right to Buy)	17,060	$0.00	$0.00
Exercise	Ordinary Shares	4,107	$37.00	$152K
Sale	Ordinary Shares	4,107	$46.49	$191K
Exercise	Ordinary Shares	17,060	$20.18	$344K
Sale	Ordinary Shares	17,060	$46.43	$792K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 25,996 shares (Direct)

Footnotes (5)

F1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
F2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.
F3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote
F4. The Stock Option vested in full on February 25, 2022.
F5. The Stock Option vested in full on June 13, 2024.

Key Figures

Shares sold: 21,167 shares Sale price (17,060 shares): $46.43 per share Sale price (4,107 shares): $46.49 per share +3 more

6 metrics

Shares sold 21,167 shares Ordinary Shares sold in open-market transactions on June 30, 2026

Sale price (17,060 shares) $46.43 per share Weighted average price for 17,060 Ordinary Shares sold

Sale price (4,107 shares) $46.49 per share Weighted average price for 4,107 Ordinary Shares sold

Options exercised (20.18) 17,060 shares at $20.18 Ordinary Shares acquired via option exercise

Options exercised (37.00) 4,107 shares at $37.00 Ordinary Shares acquired via option exercise

Shares owned after 25,996 shares Direct Ordinary Share holdings after June 30, 2026 transactions

Key Terms

Rule 10b5-1, weighted average price, Stock Option (Right to Buy), Ordinary Shares, +1 more

5 terms

Rule 10b5-1 regulatory

"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"

Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Stock Option (Right to Buy) financial

"security_title: "Stock Option (Right to Buy)""

Ordinary Shares financial

"security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did uniQure (QURE) director Jack Kaye do in this Form 4?

Jack Kaye exercised stock options and sold Ordinary Shares in uniQure. He exercised options for 21,167 shares and sold the same number in open-market transactions, ending with direct ownership of 25,996 shares.

How many uniQure (QURE) shares did Jack Kaye sell and at what prices?

He sold 21,167 Ordinary Shares of uniQure. The weighted average sale prices were about $46.43 for 17,060 shares and $46.49 for 4,107 shares, across multiple trades within narrow price ranges.

What stock options did Jack Kaye exercise in uniQure (QURE)?

He exercised options covering 21,167 Ordinary Shares in total. This included 17,060 shares at an exercise price of $20.18 and 4,107 shares at an exercise price of $37.00, fully using those option grants.

Was Jack Kaye’s uniQure (QURE) trading done under a Rule 10b5-1 plan?

Yes. The filing states the transactions were executed under a sales plan adopted on June 16, 2025, intended to comply with Rule 10b5-1, meaning the trades were pre-scheduled rather than timed discretionarily.

How many uniQure (QURE) shares does Jack Kaye own after these transactions?

Following the reported exercises and sales, Jack Kaye directly owns 25,996 Ordinary Shares of uniQure. This figure reflects his remaining equity stake after the net sale of 21,167 shares on June 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 07/02/2026 - 04:54 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kaye Jack

(Last)

(First)

(Middle)

C/O UNIQURE N.V.

PAASHEUVELWEG 25A

(Street)

AMSTERDAM

1105BP

(City)

(State)

(Zip)

NETHERLANDS

(Country)

2. Issuer Name and Ticker or Trading Symbol
uniQure N.V. [ QURE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	06/30/2026		M⁽¹⁾		4,107	A	$37	30,103	D
Ordinary Shares	06/30/2026		S⁽¹⁾		4,107	D	$46.49⁽²⁾	25,996	D
Ordinary Shares	06/30/2026		M⁽¹⁾		17,060	A	$20.18	43,056	D
Ordinary Shares	06/30/2026		S⁽¹⁾		17,060	D	$46.43⁽³⁾	25,996	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$37	06/30/2026		M⁽¹⁾			4,107	⁽⁴⁾	02/25/2031	Ordinary Shares	4,107	$0	0	D
Stock Option (Right to Buy)	$20.18	06/30/2026		M⁽¹⁾			17,060	⁽⁵⁾	06/13/2033	Ordinary Shares	17,060	$0	0	D

Explanation of Responses:

1. The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.

2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote.

3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote

4. The Stock Option vested in full on February 25, 2022.

5. The Stock Option vested in full on June 13, 2024.

	/s/ Christian Klemt, Attorney-in-Fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR